Jacqueline Henderson was appointed president, Johnson & Johnson Vision, EMEA, in April, as part of a restructuring of senior regional roles. Now overseeing this most culturally diverse of territories for both Vision Care and Surgical Vision, she explains the rationale for the internal realignment and where Johnson & Johnson Vision goes next.
Jacqueline Henderson has held a variety of roles at Johnson & Johnson in a career that began in 1996 in consumer division sales in Canada. In April 2023, she was elevated from VP, EMEA, vision care, to president, Johnson & Johnson Vision EMEA, a newly created role conferring oversight of both Vision Care and Surgical Vision.
Hers was one of four regional president postings at the time, alongside those of Lori Tierney (Americas), Jun Morimura (Japan)...
Launching In Vivo’s oncology therapeutic review series, this first instalment provides a data-led primer on the global cancer landscape. Future instalments will explore market dynamics, pipeline evolution and the innovations set to define oncology therapeutics through 2032.
Launching In Vivo’s oncology therapeutic review series, this first instalment provides a data-led primer on the global cancer landscape. Future instalments will explore market dynamics, pipeline evolution and the innovations set to define oncology therapeutics through 2032.
Launching In Vivo’s oncology therapeutic review series, this first instalment provides a data-led primer on the global cancer landscape. Future instalments will explore market dynamics, pipeline evolution and the innovations set to define oncology therapeutics through 2032.
